Medizinische Universität Graz - Research portal
Benedikt Martin |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Schwegel, N; Strohhofer, C; Kolesnik, E; Oltean, S; Hüttmair, A; Pipp, C; Benedikt, M; Verheyen, N; Gollmer, J; Ablasser, K; Wallner, M; Santner, V; Tripolt, N; Pferschy, P; Zechner, P; Alber, H; Siller-Matula, JM; Kopp, K; Zirlik, A; Aziz, F; Sourij, H; von, Lewinski, D
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Clin Res Cardiol. 2025; 114(5):629-639
Doi: 10.1007/s00392-024-02523-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Case Report
** Benedikt, M; Manninger, M; Eberl, AS; von Lewinski, D; Scherr, D
Post-traumatic ventricular septal defect manifesting as intermittent third-degree atrioventricular block: a case report
EUR HEART J-CASE REP. 2025; 9(4): ytaf172
Doi: 10.1093/ehjcr/ytaf172
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2024
Full paper/article (Journal)
** Aziz, F; Tripolt, NJ; Pferschy, PN; Scharnagl, H; Abdellatif, M; Oulhaj, A; Benedikt, M; Kolesnik, E; von, Lewinski, D; Sourij, H
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.
Cardiovasc Diabetol. 2024; 23(1): 145
Doi: 10.1186/s12933-024-02221-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Benedikt, M; Aziz, F; Fröschl, T; Strohhofer, C; Kolesnik, E; Tripolt, N; Pferschy, P; Wallner, M; Bugger, H; Zirlik, A; Scherr, D; Sourij, H; von, Lewinski, D
Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin.
Sci Rep. 2024; 14(1): 15083
Doi: 10.1038/s41598-024-64175-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Benedikt, M; Oulhaj, A; Rohrer, U; Manninger, M; Tripolt, NJ; Pferschy, PN; Aziz, F; Wallner, M; Kolesnik, E; Gwechenberger, M; Martinek, M; Nürnberg, M; Roithinger, FX; Steinwender, C; Widkal, J; Leiter, S; Zirlik, A; Stühlinger, M; Scherr, D; Sourij, H; von, Lewinski, D
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.
NEJM Evid. 2024; 3(10):EVIDoa2400147
Doi: 10.1056/EVIDoa2400147
PubMed
FullText
FullText_MUG
** de, Zegher, I; Norak, K; Steiger, D; Müller, H; Kalra, D; Scheenstra, B; Cina, I; Shulz, S; Uma, K; Kalendralis, P; Lotmam, EM; Benedikt, M; Dumontier, M; Celebi, R
Artificial intelligence based data curation: enabling a patient-centric European health data space.
Front Med (Lausanne). 2024; 11: 1365501
Doi: 10.3389/fmed.2024.1365501
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Sourij, C; Oulhaj, A; Aziz, F; Tripolt, NJ; Aberer, F; Pferschy, PN; Postula, M; Drexel, H; Benedikt, M; Kolesnik, E; Pieber, TR; Bugger, H; von, Lewinski, D; Sourij, H
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.
Diabetes Obes Metab. 2024; 26(5): 1971-1975.
Doi: 10.1111/dom.15477
Web of Science
PubMed
FullText
FullText_MUG
2023
Full paper/article (Journal)
** Benedikt, M; Mangge, H; Aziz, F; Curcic, P; Pailer, S; Herrmann, M; Kolesnik, E; Tripolt, NJ; Pferschy, PN; Wallner, M; Zirlik, A; Sourij, H; von, Lewinski, D
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial.
Cardiovasc Diabetol. 2023; 22(1): 166
Doi: 10.1186/s12933-023-01904-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Herold, L; Bachl, E; Bugger, H; Glantschnig, T; Kolesnik, E; Verheyen, N; Benedikt, M; Wallner, M; von, Lewinski, F; Schmidt, A; Harb, S; Ablasser, K; Sacherer, M; Scherr, D; Manninger-Wünscher, M; Pätzold, S; Gollmer, J; Zirlik, A; Toth, GG
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
J Clin Med. 2023; 12(22):
Doi: 10.3390/jcm12226988
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Kolesnik, E; Aziz, F; Benedikt, M; Tripolt, NJ; Wallner, M; Pferschy, PN; von, Lewinski, F; Schwegel, N; Holman, RR; Oulhaj, A; Moertl, D; Siller-Matula, J; Sourij, H
Timing of SGLT2i initiation after acute myocardial infarction.
Cardiovasc Diabetol. 2023; 22(1): 269
Doi: 10.1186/s12933-023-02000-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Benedikt, M; Kolesnik, E; Sourij, H; von Lewinski, D
SGLT2 Inhibition in Acute Myocardial Infarction-A Comprehensive Review
REV CARDIOVASC MED. 2023; 24(2):
Doi: 10.31083/j.rcm2402032
Web of Science
FullText
FullText_MUG
Abstract (Journal)
** Benedikt, M; Kolesnik, E; Wallner, M; Hofler, G; Stangl, VM; Zirlik, A; Rainer, P
Giant cell myocarditis manifesting as severe heart failure with cardiogenic shock
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S342-S343.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Benedikt, M; Kolesnik, E; Wallner, M; Zirlik, A; Sourij, H; Tripolt, N; Aziz, F; Vonbank, A; Purkarthofer, D; Wester, S; Kopp, K; Nahler, A; von Lewinski, D
Impact of the SGLT2-inhibitor Empagliflozin on inflammatory biomarkers in acute myocardial infarction-a post-hoc analysis of the EMMY trial
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S359-S360.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Benedikt, M; Prenner, G; Sereinigg, M; Eberl, A; Manninger-Wunscher, M; Rohrer, U; Riedlbauer, R; Zirlik, A; Zweiker, D; Bisping, E; Lercher, P; Scherr, D
Electroanatomic mapping system guided His Bundle Pacemaker Implantation: Experience of the His Bundle Registry Graz
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S346-S346.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Curcic, P; Herrmann, M; Pailer, S; Mangge, H; Benedikt, M; von Lewinski, D; Aziz, F; Kolesnik, E; Tripolt, NJ; Pferschy, P; Wallner, M; Zirlik, A; Sourij, H
Impact of the SGLT2-inhibitor Empagliflozin on inflammatory biomarkers in acute coronary syndrome-a post-hoc analysis of the EMMY trial
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S361-S361.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Eberl, A; Manninger, M; Rohrer, U; Zweiker, D; Reischl, A; Kurath-Koller, S; Benedikt, M; Bisping, E; Lercher, P; Zirlik, A; Scherr, D
Incidence, types and predictors of AF recurrence after AF ablation with pulsed field ablation. A single-centre experience
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S490-S491.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Strohhofer, C; Oltean, S; Huttmair, A; Pipp, C; Benedikt, M; Wallner, M; Verheyen, N; Gollmer, J; Ablasser, K; Hanfstingl-Sinz, D; Andorfer, J; Pachinger-Possl, S; Brunner, M; Rogozarski, J; Kolesnik, E
The SGLT2-inhibitor Empagliflozin improves Parameters of Diastolic Function after Myocardial Infarction measured by Echocardiography-a Single Center Sub Analysis of the EMMY-Trial
WIEN KLIN WOCHENSCHR. 2023; 135: S343-S345.
[Poster]
Web of Science
** Wallner, M; Sourij, C; Aziz, F; Tripolt, N; Siller-Matula, J; Saly, C; Hoppe, U; Mayrhofer, G; Alber, H; Steinwender, C; Mortl, D; Zechner, P; Weidinger, F; Postula, M; Benedikt, M; Kolesnik, E; Oulhaj, A; Sourij, H; von Lewinski, D
Effects of empagliflozin in women and men with acute myocardial infarction-an analysis from the EMMY trial
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S359-S359.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
2022
Full paper/article (Journal)
** von, Lewinski, D; Benedikt, M; Alber, H; Debrauwere, J; Smits, PC; Édes, I; Kiss, RG; Merkely, B; Nagy, GG; Ptaszynski, P; Zarebinski, M; Kubica, J; Kleinrok, A; Coats, AJS; Wallner, M
Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 Trial.
J CLIN MED. 2022; 11(19):
Doi: 10.3390/jcm11195728
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Kolesnik, E; Tripolt, NJ; Pferschy, PN; Benedikt, M; Wallner, M; Alber, H; Berger, R; Lichtenauer, M; Saely, CH; Moertl, D; Auersperg, P; Reiter, C; Rieder, T; Siller-Matula, JM; Gager, GM; Hasun, M; Weidinger, F; Pieber, TR; Zechner, PM; Herrmann, M; Zirlik, A; Holman, RR; Oulhaj, A; Sourij, H
Empagliflozin in acute myocardial infarction: the EMMY trial.
Eur Heart J. 2022; 43(41):4421-4432
Doi: 10.1093/eurheartj/ehac494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Tripolt, NJ; Sourij, H; Pferschy, PN; Oulhaj, A; Alber, H; Gwechenberger, M; Martinek, M; Seidl, S; Moertl, D; Nürnberg, M; Roithinger, FX; Steinwender, C; Stühlinger, M; Zirlik, A; Benedikt, M; Kolesnik, E; Wallner, M; Rohrer, U; Manninger, M; Scherr, D, , ERASe, study, group
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III study.
Am Heart J. 2022; 246:152-160
Doi: 10.1016/j.ahj.2022.01.008
Web of Science
PubMed
FullText
FullText_MUG
Review
** Kolesnik, E; Scherr, D; Rohrer, U; Benedikt, M; Manninger, M; Sourij, H; von, Lewinski, D
SGLT2 Inhibitors and Their Antiarrhythmic Properties.
Int J Mol Sci. 2022; 23(3):
Doi: 10.3390/ijms23031678
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Eberl, A; Manninger, M; Rohrer, U; Benedikt, M; Kurath-Koller, S; Pratl, B; Loibnegger, S; Andrecs, L; Zirlik, A; Scherr, D
Pulsed field ablation (PFA) for pulmonary vein isolation in patients with atrial fibrillation: A single-center experience
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):166-166.
[Poster]
Web of Science
2021
Review
** von, Lewinski, D; Benedikt, M; Tripolt, N; Wallner, M; Sourij, H; Kolesnik, E
Can sodium-glucose cotransporter 2 inhibitors be beneficial in patients with acute myocardial infarction?
Kardiol Pol. 2021; 79(5):503-509
Doi: 10.33963/KP.15969
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG